Your browser doesn't support javascript.
loading
Mostrar: 20 | 50 | 100
Resultados 1 - 2 de 2
Filtrar
Más filtros











Base de datos
Intervalo de año de publicación
1.
Dig Dis Sci ; 62(1): 93-104, 2017 01.
Artículo en Inglés | MEDLINE | ID: mdl-27864656

RESUMEN

AIM: The objective was to evaluate the effects of nitric oxide (NO) and hydrogen sulfide (H2S) donors and possible interactions between these two systems in modulating gastric function. METHODS: Mice received saline, sodium nitroprusside (SNP), or sodium hydrosulfite (NaHS), and after 1 h, the animals were killed for immunofluorescence analysis of CSE or eNOS expressions, respectively. Other groups received saline, SNP, NaHS, Lawesson's reagent (H2S donor), PAG + SNP, L-NAME, L-NAME + NaHS, or L-NAME + Lawesson's reagent. Then, the gastric secretions (mucous and acid), gastric blood flow, gastric defense against ethanol, and gastric motility (gastric emptying and gastric contractility) were evaluated. RESULTS: SNP and NaHS increased the expression of CSE or eNOS, respectively. SNP or Lawesson's reagent did not alter gastric acid secretion but increased mucus production, and these effects reverted with PAG and L-NAME treatment, respectively. SNP or NaHS increased gastric blood flow and protected the gastric mucosa against ethanol injury, and these effects reverted with PAG and L-NAME treatments, respectively. SNP delayed gastric emptying when compared with saline, and PAG partially reversed this effect. NaHS accelerate gastric emptying, and L-NAME partially reversed this effect. SNP and NaHS alone induced gastric fundus and pylorus relaxation. However, pretreatment with PAG or L-NAME reversed these relaxant effects only in the pylorus but not in the gastric fundus. CONCLUSION: NO and H2S interact in gastric physiological functions, and this "cross-talk" is important in the control of mucus secretion, gastric blood flow, gastric mucosal defense, and gastric motility, but not in the control of basal gastric acid secretion.


Asunto(s)
Cistationina gamma-Liasa/efectos de los fármacos , Vaciamiento Gástrico/efectos de los fármacos , Donantes de Óxido Nítrico/farmacología , Óxido Nítrico Sintasa de Tipo III/efectos de los fármacos , Nitroprusiato/farmacología , Estómago/efectos de los fármacos , Sulfuros/farmacología , Alquinos/farmacología , Animales , Depresores del Sistema Nervioso Central/farmacología , Cistationina gamma-Liasa/antagonistas & inhibidores , Cistationina gamma-Liasa/metabolismo , Interacciones Farmacológicas , Inhibidores Enzimáticos/farmacología , Etanol/farmacología , Técnica del Anticuerpo Fluorescente , Ácido Gástrico/metabolismo , Fundus Gástrico/efectos de los fármacos , Mucosa Gástrica/efectos de los fármacos , Mucosa Gástrica/metabolismo , Glutatión/efectos de los fármacos , Glutatión/metabolismo , Glicina/análogos & derivados , Glicina/farmacología , Flujometría por Láser-Doppler , Masculino , Malondialdehído/metabolismo , Ratones , Moco/efectos de los fármacos , Moco/metabolismo , Contracción Muscular/efectos de los fármacos , NG-Nitroarginina Metil Éster/farmacología , Óxido Nítrico Sintasa de Tipo III/antagonistas & inhibidores , Óxido Nítrico Sintasa de Tipo III/metabolismo , Píloro/efectos de los fármacos , Ratas , Ratas Wistar , Flujo Sanguíneo Regional , Estómago/irrigación sanguínea
2.
Mar Drugs ; 9(11): 2188-2200, 2011.
Artículo en Inglés | MEDLINE | ID: mdl-22163181

RESUMEN

The aim of the present study was to investigate the gastroprotective activity of a sulfated-polysaccharide (PLS) fraction extracted from the marine red algae Gracilaria caudata and the mechanism underlying the gastroprotective activity. Male Swiss mice were treated with PLS (3, 10, 30 and 90 mg·kg(-1), p.o.), and after 30 min, they were administered 50% ethanol (0.5 mL/25 g(-1), p.o.). One hour later, gastric damage was measured using a planimeter. Samples of the stomach tissue were also obtained for histopathological assessment and for assays of glutathione (GSH) and malondialdehyde (MDA). Other groups were pretreated with l-NAME (10 mg·kg(-1), i.p.), dl-propargylglycine (PAG, 50 mg·kg(-1), p.o.) or glibenclamide (5 mg·kg(-1), i.p.). After 1 h, PLS (30 mg·kg(-1), p.o.) was administered. After 30 min, ethanol 50% was administered (0.5 mL/25 g(-1), p.o.), followed by sacrifice after 60 min. PLS prevented-ethanol-induced macroscopic and microscopic gastric injury in a dose-dependent manner. However, treatment with l-NAME or glibenclamide reversed this gastroprotective effect. Administration of propargylglycine did not influence the effect of PLS. Our results suggest that PLS has a protective effect against ethanol-induced gastric damage in mice via activation of the NO/K(ATP) pathway.


Asunto(s)
Etanol/toxicidad , Gracilaria/química , Polisacáridos/farmacología , Gastropatías/prevención & control , Alquinos/farmacología , Animales , Relación Dosis-Respuesta a Droga , Glutatión/metabolismo , Gliburida/farmacología , Glicina/análogos & derivados , Glicina/farmacología , Canales KATP/metabolismo , Masculino , Malondialdehído/metabolismo , Ratones , NG-Nitroarginina Metil Éster/farmacología , Óxido Nítrico/metabolismo , Polisacáridos/administración & dosificación , Polisacáridos/aislamiento & purificación , Sustancias Protectoras/administración & dosificación , Sustancias Protectoras/aislamiento & purificación , Sustancias Protectoras/farmacología , Gastropatías/inducido químicamente
SELECCIÓN DE REFERENCIAS
DETALLE DE LA BÚSQUEDA